BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31399258)

  • 1. A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer.
    Li K; Pan W; Ma Y; Xu X; Gao Y; He Y; Wei L; Zhang J
    Pathol Res Pract; 2019 Oct; 215(10):152573. PubMed ID: 31399258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3β/β-catenin signaling pathway in breast cancer.
    Li K; Ma YB; Zhang Z; Tian YH; Xu XL; He YQ; Xu L; Gao Y; Pan WT; Song WJ; He X; Wei L
    Cancer Med; 2018 Aug; 7(8):3875-3888. PubMed ID: 29968965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
    Xie X; Li H; Pan J; Han X
    Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer.
    Wang C; Xu J; Fu H; Zhang Y; Zhang X; Yang D; Zhu Z; Wei Z; Hu Z; Yan R; Cai Q
    J Cell Mol Med; 2018 Oct; 22(10):5020-5028. PubMed ID: 30079558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXB5 promotes the progression of breast cancer through wnt/beta-catenin pathway.
    Zhang J; Zhang S; Li X; Zhang F; Zhao L
    Pathol Res Pract; 2021 Aug; 224():153117. PubMed ID: 34118725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer.
    Li K; Pan WT; Ma YB; Xu XL; Gao Y; He YQ; Wei L; Zhang JW
    Breast Cancer; 2020 May; 27(3):363-371. PubMed ID: 31728872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-determining Region Y-box transcription factor 13 promotes breast cancer cell proliferation and glycolysis by activating the tripartite motif containing 11-mediated Wnt/β-catenin signaling pathway.
    Jin X; Shao X; Pang W; Wang Z; Huang J
    Bioengineered; 2022 May; 13(5):13033-13044. PubMed ID: 35611828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF281 Regulates Cell Proliferation, Migration and Invasion in Colorectal Cancer through Wnt/β-Catenin Signaling.
    Qin CJ; Bu PL; Zhang Q; Chen JT; Li QY; Liu JT; Dong HC; Ren XQ
    Cell Physiol Biochem; 2019; 52(6):1503-1516. PubMed ID: 31112017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway.
    Xueqin T; Jinhong M; Yuping H
    Bioengineered; 2021 Dec; 12(2):11567-11575. PubMed ID: 34889158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/β-catenin signaling pathway.
    Li M; Cai H; Yang Y; Zhang J; Sun K; Yan Y; Qu H; Wang W; Wang J; Duan X
    Oncol Rep; 2016 Aug; 36(2):936-44. PubMed ID: 27277008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.
    Gu X; Wang Y; Wang H; Ni Q; Zhang C; Zhu J; Huang W; Xu P; Mao G; Yang S
    Med Oncol; 2015 Jul; 32(7):195. PubMed ID: 26033031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway.
    Su K; Huang L; Li W; Yan X; Li X; Zhang Z; Jin F; Lei J; Ba G; Liu B; Wang X; Wang Y
    J Surg Res; 2013 Nov; 185(1):255-63. PubMed ID: 23880650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripartite motif 31 drives gastric cancer cell proliferation and invasion through activating the Wnt/β-catenin pathway by regulating Axin1 protein stability.
    Feng Q; Nie F; Gan L; Wei X; Liu P; Liu H; Zhang K; Fang Z; Wang H; Fang N
    Sci Rep; 2023 Nov; 13(1):20099. PubMed ID: 37973999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
    Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
    World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
    Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
    Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
    Liu F; Liu Y; Shen J; Zhang G; Han J
    Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.